Corbus appoints Ian Hodgson as COO effective March 15, 2025

Corbus Pharmaceuticals Holdings, Inc.

Ian Hodgson, 52, previously Head of Operations, named COO effective March 15, 2025.
Annual base salary of £327,869; eligible for annual bonus up to 40% of base salary.
Employment subject to 3-month notice period; non-compete for 3 months, non-solicit for 6 months post-termination.
Dr. Hodgson holds a PhD in Medical Microbiology, over 25 years experience in drug development.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ian Hodgson

Chief Operating Officer

CRBP · Corbus Pharmaceuticals Holdings, Inc.

Effective: 2025-03-15
Filed: March 18, 2025, 7:59 PM ET

On March 13, 2025, the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) appointed Ian Hodgson as Chief Operating Officer effective March 15, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ian Hodgson was appointed as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On March 13, 2025, the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) appointed Ian Hodgson as Chief Operating Officer effective March 15, 2025.

View on SEC.gov

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-041254

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.